As the U.S. coronavirus case count passed 4.3 million on Monday, companies launched the final phase of testing for two potential COVID-19 vaccines. In one trial begun on Monday, the first of 30,000 volunteers were either given a vaccine developed by Moderna Inc. and the U.S. National Institutes of Health or a placebo shot, the… read on >



















